Patents by Inventor Fernando Doñate

Fernando Doñate has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
    Patent number: 7119069
    Abstract: Human kininogen domain 3 (HK-D3) polypeptides and biologically active variants and derivatives of HK-D3 are anti-angiogenic. These molecules are used to inhibit angiogenesis or treat a disease or condition in which angiogenesis is pathogenic. Because of their anti-angiogenic potential, these molecules compounds are useful in the treatment of cancer by inhibiting or reversing the growth of primary or metastatic tumors.
    Type: Grant
    Filed: March 24, 2006
    Date of Patent: October 10, 2006
    Assignee: Attenuon, LLC
    Inventors: Fernando Doñate, Andrew P. Mazar
  • Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent
    Patent number: 7098187
    Abstract: Human kininogen domain 3 (HK-D3) polypeptides and biologically active variants and derivatives of HK-D3 are anti-angiogenic. These molecules are used to inhibit angiogenesis or treat a disease or condition in which angiogenesis is pathogenic. Because of their anti-angiogenic potential, these molecules are useful in the treatment of cancer by inhibiting or reversing the growth of primary or metastatic tumors.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: August 29, 2006
    Assignee: Attenuon, LLC
    Inventors: Fernando Doñate, Andrew P. Mazar